Terms: = Brain cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
225 results:
1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract] [Full Text] [Related]
2. OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses.
Zheng Y; Wang X; Ji Q; Fang A; Song L; Xu X; Lin Y; Peng Y; Yu J; Xie L; Chen F; Li X; Zhu S; Zhang B; Zhou L; Yu C; Wang Y; Wang L; Hu H; Zhang Z; Liu B; Wu Z; Li W
Cancer Lett; 2024 May; 589():216834. PubMed ID: 38537773
[TBL] [Abstract] [Full Text] [Related]
3. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract] [Full Text] [Related]
4. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
[TBL] [Abstract] [Full Text] [Related]
5. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
Xi S; Jiang S; Li H; Huang Q; Lu J; Zhang X; Li Z; Zeng J
Int J Cancer; 2024 Jul; 155(1):172-183. PubMed ID: 38411299
[TBL] [Abstract] [Full Text] [Related]
6. Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction - single centre experience.
Ma H; Zeng S; Xie D; Zeng W; Huang Y; Mazu L; Zhu N; Yang Z; Chu J; Zhao J
Radiol Oncol; 2024 Mar; 58(1):23-32. PubMed ID: 38378035
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and molecular study of radiation-induced gliomas.
Trkova K; Sumerauer D; Bubenikova A; Krskova L; Vicha A; Koblizek M; Zamecnik J; Jurasek B; Kyncl M; Malinova B; Ondrova B; Jones DTW; Sill M; Strnadova M; Stolova L; Misove A; Benes V; Zapotocky M
Sci Rep; 2024 Feb; 14(1):3118. PubMed ID: 38326438
[TBL] [Abstract] [Full Text] [Related]
8. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
9. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas.
Liang Q; Jing H; Shao Y; Wang Y; Zhang H
Clin Neuroradiol; 2024 Mar; 34(1):33-43. PubMed ID: 38277059
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
11. A novel grading system combining histological grade and cdkn2a homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
Xi S; Huang Q; Zeng J
J Neuropathol Exp Neurol; 2024 Jan; 83(2):125-130. PubMed ID: 38175671
[TBL] [Abstract] [Full Text] [Related]
12. Application of novel PACS-based informatics platform to identify imaging based predictors of cdkn2a allelic status in glioblastomas.
Tillmanns N; Lost J; Tabor J; Vasandani S; Vetsa S; Marianayagam N; Yalcin K; Erson-Omay EZ; von Reppert M; Jekel L; Merkaj S; Ramakrishnan D; Avesta A; de Oliveira Santo ID; Jin L; Huttner A; Bousabarah K; Ikuta I; Lin M; Aneja S; Turowski B; Aboian M; Moliterno J
Sci Rep; 2023 Dec; 13(1):22942. PubMed ID: 38135704
[TBL] [Abstract] [Full Text] [Related]
13. p16 Immunohistochemistry as a Screening Tool for Homozygous cdkn2a Deletions in CNS Tumors.
Zschernack V; Andreiuolo F; Dörner E; Wiedey A; Jünger ST; Friker LL; Maruccia R; Pietsch T
Am J Surg Pathol; 2024 Jan; 48(1):46-53. PubMed ID: 37947008
[TBL] [Abstract] [Full Text] [Related]
14. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
15. A novel MRI-based deep learning networks combined with attention mechanism for predicting cdkn2a/B homozygous deletion status in IDH-mutant astrocytoma.
Zhang L; Wang R; Gao J; Tang Y; Xu X; Kan Y; Cao X; Wen Z; Liu Z; Cui S; Li Y
Eur Radiol; 2024 Jan; 34(1):391-399. PubMed ID: 37553486
[TBL] [Abstract] [Full Text] [Related]
16. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
[TBL] [Abstract] [Full Text] [Related]
17. Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas.
Lasocki A; Buckland ME; Molinaro T; Xie J; Whittle JR; Wei H; Gaillard F
Neuroradiology; 2023 Aug; 65(8):1215-1223. PubMed ID: 37316586
[TBL] [Abstract] [Full Text] [Related]
18. Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
Lee K; Kim SI; Kim EE; Shim YM; Won JK; Park CK; Choi SH; Yun H; Lee H; Park SH
Sci Rep; 2023 Apr; 13(1):6761. PubMed ID: 37185778
[TBL] [Abstract] [Full Text] [Related]
19. Molecular imaging of gliomas.
Metz MC; Wiestler B
Clin Neuropathol; 2023; 42(4):131-139. PubMed ID: 36999510
[TBL] [Abstract] [Full Text] [Related]
20. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
Tamura R; Iwanami A; Ohara K; Nishimoto M; Pareira ES; Miwa T; Tsuzaki N; Kuranari Y; Morimoto Y; Toda M; Okano H; Nakamura M; Yoshida K; Sasaki H
Brain Tumor Pathol; 2023 Apr; 40(2):109-123. PubMed ID: 36892668
[TBL] [Abstract] [Full Text] [Related]
[Next]
